A variety of 2-(aminomethyl)aziridines was prepared and converted into the corresponding 1,2,3-triaminopropanes through a novel, microwave-assisted and regioselective ring opening by diethylamine in acetonitrile. Antiplasmodial assays revealed antimalarial activity for 2-[(1,2,4-triazol-1-yl)methyl]aziridines and 2-(N,N-diethylaminomethyl)aziridines, as well as for the corresponding 1-(diethylamino)propanes obtained through ring opening, pointing to the relevance of both the 2-(aminomethyl)aziridine and the 1,2,3-triaminopropane unit as novel antimalarial pharmacophores.
Introduction
With 247 million clinical cases and nearly one million deaths in 2008, mostly among African children, malaria remains a major issue in health control [1] . Quinoline containing compounds, such as the potent and inexpensive chloroquine (CQ) [2, 3, 4] have a long tradition in the treatment of malaria, and systematic modification has led to a variety of antimalarial drugs with diverse substitutions around the quinoline ring [5, 6] . However, the spread of chloroquine-resistant Plasmodium falciparum strains has dashed hopes of global malaria eradication and has complicated the clinical management of malaria in endemic areas.
Consequently, many efforts are devoted to the design and synthesis of novel and structurally 2 diverse compounds with potential antimalarial activity. Recently, the β-amino alcohol moiety has been introduced as a promising antimalarial pharmacophore, and the synthesis of a number of novel aminopropanols with significant antimalarial activity has revealed the medicinal importance of this class of glycerol analogues [7, 8, 9] . Their aza-derivatives, i.e. 1,2,3-triaminopropanes, however, have not been the subject of antimalarial screening up to now.
In this paper, the preparation and biological evaluation of novel 2-(aminomethyl)aziridines and 1,2,3-triaminopropanes is described as potential new lead compounds within the framework of malaria management and treatment.
The aziridine moiety represents one of the most valuable three-membered ring systems in organic chemistry [10, 11, 12, 13, 14, 15, 16, 17] , and the regiocontrolled ring opening of Csubstituted aziridines constitutes a powerful approach towards the preparation of a large variety of nitrogen-containing target compounds. In contrast to their activated counterparts, non-activated aziridines have been evaluated to a limited extent up to now, both from a synthetic and a pharmacological point of view. Due to the presence of an electron-donating substituent at nitrogen, the latter aziridines have to be activated toward aziridinium ion intermediates prior to ring opening [18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31] . Within the present work, the scarcely studied subclass of non-activated 1-alkyl-2-(aminomethyl)aziridines [32, 33, 34, 35, 36, 37, 38, 39] was employed as a source of substrates for the development of a novel entry toward the biologically relevant 1,2,3-triaminopropane unit through a highly regioselective and microwave-assisted ring opening by diethylamine in acetonitrile.
Results and discussion -Synthesis
Given the recently disclosed antimalarial properties of aminopropanols [7, 8, 9] , and taking structure-activity relationship studies with regard to chloroquine into account [40] , the elaboration of a 1,2,3-triaminopropane unit substituted with an aryl group, a N,Ndiethylamino moiety and an azaheteroaromatic nucleus was envisaged as a potential novel antimalarial pharmacophore. From a retrosynthetic point of view, 2-(aminomethyl)aziridines can be regarded as suitable precursors for the preparation of 1,2,3-triaminopropanes through ring opening by amines. Thus, the synthesis of properly substituted aziridines, bearing an azaheteroaromatic group in their side chain, was proposed, which then could serve as eligible substrates for the preparation of the desired targets through aziridine ring opening by a nucleophilic amine.
At first, a variety of 2-(aminomethyl)aziridines 2 was prepared via coupling of different nitrogen nucleophiles with 2-(bromomethyl)aziridines 1 [41, 42, 43] , employing the electrophilicity of the latter as a convenient handle for their connection to other moieties [33] .
In order to introduce structural diversity within the amino side chain, aziridines 1 were connected to different classes of aromatic azaheterocycles such as adenine [44] , thymine and 1,2,4-triazole en route to the corresponding 2-(aminomethyl)aziridines 2a-h (Scheme 1, Table   1 ). In addition, also diethylamine was used for the preparation of 2-(N,Ndiethylaminomethyl)aziridines 2i-k in order to evaluate the difference between the presence of an aromatic azaheterocyclic moiety and a simple acyclic amino group in 1,2,3-triaminopropanes with regard to their biological activity.
The synthesis of 2-[(6-aminopurin-9-yl)methyl]aziridines 2a-c was accomplished upon treatment of 2-(bromomethyl)aziridines 1 with 1 equiv of adenine in DMF at 80 °C for 5 hours in the presence of 5 equiv of K 2 CO 3 ( Table 1 , entries 1-3). Next to the desired N9-substituted adenines 2a-c, isomeric N7-alkylation products were observed as well in minor amounts (N9/N7 ~3/1), which is in accordance with literature data on the N-alkylation of adenine [45] . The premised adenine derivatives 2a-c were isolated in pure form through crystallization. In recent years, the synthesis of functionalized adenines has gained much interest due to the pronounced biological activities, such as antitumor and antiviral, associated to this class of compounds [46, 47, 48] . Besides purines, also pyrimidines are known to be of importance as lead compounds in medicinal chemistry [48, 49, 50] . In that respect, thymine was used as a nucleophile toward the preparation of 2-[(2,4-dioxo-5-methylpyrimidin-1-yl)methyl]aziridines 2d,e upon treatment of 2-(bromomethyl)aziridines 1 with one equiv of thymine and one equiv of NaH in DMF at 80 °C for 3 hours (Table 1 , entries 4-5). The former aziridines 2d,e were obtained in good crude yields, and were purified by crystallization from CH 2 Cl 2 /Et 2 O (4/1) in order to obtain analytically pure samples (the yields in Table 1 are yields obtained after purification).
Next to DNA bases, the 1,2,4-triazole moiety was introduced as an aziridine side chain through reaction of aziridines 1 with 5 equiv of 1,2,4-triazole [51] in CH 3 CN under reflux for 2.5 d in the presence of 4 equiv of K 2 CO 3 , affording the corresponding triazoles 2f-h in good yields (Table 1 , entries 6-8) [33] . These long reaction times appeared to be necessary in order to drive the reaction to completion. Finally, a number of 2-(N,N-diethylaminomethyl)aziridines 2i-k were prepared in good yields using an excess (16 equiv) of diethylamine in methanol under reflux for one day (Table 1, The test samples were prepared to a 2 mg/mL stock solution in 10% DMSO and sonicated to enhance solubility. The samples were tested as a suspension and stock solutions were stored at -20ºC. Further dilutions were prepared on the day of the experiment.
Antiplasmodial assay
Continuous in vitro cultures of asexual erythrocyte stages of P. falciparum were maintained using a modified method of Trager and Jensen [52] . Quantitative assessment of antiplasmodial activity in vitro was determined via the parasite lactate dehydrogenase assay using a modified method described by Makler [53] . Chloroquine diphosphate (Sigma) (CQ) was used as the reference drug in all experiments. A full dose-response was performed for all compounds to determine the concentration inhibiting 50% of organism growth (IC 50 -value).
Cytotoxicity assay
The MTT-assay [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide-assay] is used as a colorimetric assay for cellular growth and survival, and compares well with other available assays [54, 55] . The tetrazolium salt MTT was used to measure all growth and chemosensitivity. Emetine dihydrochloride (Sigma) was used as the reference drug in all experiments.
The results of the biological evaluation are summarized in Table 2 for 2-(aminomethyl)aziridines 2 and in Table 3 for 1,2,3-triaminopropanes 3.
Although the aziridine moiety was initially not considered as a template for biological screening, (Table 2) . Moreover, aziridines 2h and 2i-k also showed antimalarial activity against the CQR Dd2 strain of P.
falciparum (IC 50 -values between 48.3 and 18.0 M), and low (2i-k) or no (2h) cytotoxicity (Table 2) .
With regard to the screening of 1,2,3-triaminopropanes 3, all representatives showed weak to potent antiplasmodial activities against the chloroquine sensitive (CQS) strain of P.
falciparum, with IC 50 -values ranging from 214.1 to 2.0 M (Table 3) , with some degree of cross resistance being displayed by 3h. In particular, triazoles 3g,h and 1,3-bis(diethylamino)propanes 3j,k exhibited superior antimalarial activities with IC 50 -values between 8.4 and 2.0 M. Furthermore, triazoles 3f-h and 1,3-bis(diethylamino)propanes 3i-k were tested against the chloroquine-resistant (CQR) strain of P. falciparum, again showing antiplasmodial activities. Interestingly, the in vitro cytotoxicity results showed that only compounds 3j and 3k have SI"s of 9 and 24, respectively (Table 3) , whereas all other compounds did not show cytotoxicity at the concentrations tested. pointing to the promising potential of aziridines 2 and aminopropanes 3 within the context of the development of novel antimalarial agents. In that respect, structure/activity relationship studies should be performed as well in the future. It is noteworthy that these compounds were synthesized in racemic form, and it is conceivable that enantiomerically pure variants could deliver superior activities. A ramp time of maximum 5 minutes is used during which the temperature increases from room temperature to the desired one. This temperature is maintained during the course of the reaction for the indicated time.
Synthesis of 2-(6-aminopurin-9-yl)methyl-1-(arylmethyl)aziridines (2a-c).
General 
2-(6-Aminopurin-9-yl)methyl-1-(phenylmethyl)aziridine (2a

2-(6-Aminopurin-9-yl)methyl-1-[(4-chlorophenyl)methyl]aziridine (2b
2-(6-Aminopurin-9-yl)methyl-1-[(4-methoxyphenyl)methyl]aziridine (2c).
Recrystallization 
Synthesis of 1-arylmethyl-2-[(2,4-dioxo-5-methylpyrimidin-1-yl)methyl]aziridines (2d-e).
General procedure: To a solution of 1-arylmethyl-2-(bromomethyl)aziridine 1 [41, 42, 43] (5 mmol) and thymine (5 mmol, 1 equiv) in dimethylformamide (25 mL) was added sodium hydride (60% in mineral oil; 5 mmol, 1 equiv). After stirring for 3 h at 80 °C, the solvent was removed under reduced pressure. The residue was poured into water (10 mL), extracted with chloroform (3 x 15 mL) and washed with brine (3 x 15 mL). The combined organic layers were dried over anhydrous magnesium sulfate. Filtration of the drying agent and removal of the solvent in vacuo afforded the crude products 2d-e, which were purified by recrystallization from dichloromethane/ether (4/1).
1-(4-Chlorophenyl)methyl-2-[(2,4-dioxo-5-methylpyrimidin-1-yl)methyl]aziridine (2d).
Recrystallization [33] . General procedure: To a solution of 1-arylmethyl-2-(bromomethyl)aziridine 1 [41, 42, 43 ] (7.78 mmol) and 1,2,4-triazole (38.9 mmol, 5 equiv) in acetonitril (100 mL) was added potassium carbonate (31.12 mmol, 4 equiv), after which the resulting suspension was heated under reflux for 2 days. Afterwards, the solvent was removed under reduced pressure. The residue was poured into 75 mL of 1 M sodium hydroxide solution and extracted with diethyl ether (3 x 30 mL). The combined organic layers were dried over anhydrous potassium carbonate.
Synthesis of 1-arylmethyl-2-[(1,2,4-triazol-1-yl)methyl]aziridines (2f-h)
Filtration of the drying agent and removal of the solvent in vacuo afforded the crude products 2f-h, which were purified by column chromatography on silica gel (CHCl 3 /MeOH 97/3). 
1-(4-
Methoxyphenyl
1-(4-Chlorophenyl)methyl-2-[(N,N-diethylamino)methyl]aziridine (2j
Synthesis of 1-(6-aminopurin-9-yl)-2-(arylmethyl)amino-3-diethylaminopropanes (3a-c).
General procedure: In a 10 mL thick walled Pyrex reaction vessel, 2-(6-aminopurin-9-yl)methyl-1-(arylmethyl)aziridine 2a-c (0.89 mmol), diethylamine (17.8 mmol) and diethylamine hydrochloride (8.9 mmol) were dissolved in acetonitrile (6 mL 
1-(6-Aminopurin-9-yl)-2-[(4-chlorophenyl)methyl]amino-3-diethylaminopropane (3b).
Synthesis of 2-(arylmethyl)amino-3-diethylamino-1-(1,2,4-triazol-1-yl)propanes (3f-h).
The procedure for the synthesis of compounds 3a-c was applied for the preparation of 2-(arylmethyl)amino-3-diethylamino-1-(1,2,4-triazol-1-yl)propanes 3f-h. The crude products 3f-h were purified by column chromatography on aluminum oxide (CH 2 Cl 2 /MeOH 99/1). -1-(1,2,4-triazol-1-yl 
3-Diethylamino-2-(phenylmethyl)amino
